NASDAQ: HERAFtac Hera Acquisition Corp Stock
$10.16+0.00 (+0%)
Updated Feb 3, 2023
HERA Price
$10.16
Fair Value Price
$10.16
Market Cap
$1.11B
52 Week Low
$9.71
52 Week High
$10.18
P/E
46.16x
P/B
-33.89x
P/S
N/A
PEG
0.06x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$23.90M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$1M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HERA Overview
FTAC Hera Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets fintech companies. FTAC Hera Acquisition was incorporated in 2021 and is based in Philadelphia, PA.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HERA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HERA ($10.16) is undervalued by 0.01% relative to our estimate of its Fair Value price of $10.16 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HERA ($10.16) is not significantly undervalued (0.01%) relative to our estimate of its Fair Value price of $10.16 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HERA ($10.16) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HERA due diligence checks available for Premium users.
Be the first to know about important HERA news, forecast changes, insider trades & much more!
HERA News
Valuation
HERA fair value
Fair Value of HERA stock based on Discounted Cash Flow (DCF)
Price
$10.16
Fair Value
$10.16
Overvalued by
0.04%
HERA ($10.16) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HERA ($10.16) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HERA ($10.16) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
HERA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
46.16x
Industry
15.88x
Market
15.09x
HERA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HERA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
HERA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-33.89x
Industry
-34.09x
HERA price to earnings growth (PEG)
For valuing profitable companies with growth potential
HERA is good value based... subscribe to Premium to read more.
PEG Value Valuation
HERA's financial health
Profit margin
Revenue
$0.0
Net Income
$6.8M
Profit Margin
0%
HERA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$856.7M
Liabilities
$32.9M
Debt to equity
-1.01
HERA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HERA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$154.5k
Investing
$0.0
Financing
$0.0
HERA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HERA vs Shell Company Stocks
Ftac Hera Acquisition Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.